Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

SPC decision spells bad news for second medical use

Charlotte Kilpatrick
July 16, 2020
Share
second-medical-use-cjeu.jpg

In-house lawyers call the recent CJEU ruling on SPCs ‘disappointing’ but welcome the clarity provided in the decision

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Tags

IP StrategyNewsEuropean UnionPatentsEuropeJurisdictions
kilpatrick-charlotte-300px.png
Charlotte Kilpatrick
Reporter Managing IP
Contact
Charlotte reports on patent-related issues. She often covers the European market, focusing on developments including FRAND, licensing and trade secrets. She is particularly interested in how new technologies affect IP challenges in the pharmaceutical industry.
more from across site and ros bottom lb

More from across our site

commission.jpg
This week on MIP: Unitary SPCs; Delhi victory for Ericsson
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Rory O’Neill, March 31, 2023
Christian-Archambeau-EUIPO-Alicante.jpg
Exclusive: Council chasing EUIPO for Archambeau assessment
The EUIPO management board must provide the Council of the EU with a performance assessment before it can remove the executive director
Rory O’Neill, March 30, 2023
People communicate European Commission building.Brussels, Belgium - 02 Mar 2011
Unitary SPC will join SEPs in EU patent shake-up
The European Commission confirmed that plans for a unitary SPC will be published in April alongside reforms to the SEP system
Rory O’Neill, March 30, 2023
Ericsson.jpeg
Delhi High Court doubles Ericsson royalty in SEP appeal
The court held that SEP implementers could be injuncted or directed to pay royalties before trial if they are deemed to be unwilling licensees
Sukanya Sarkar, March 30, 2023
EPO
End of ‘painful’ EPO plausibility test a win for patentees
Patentees should feel cautious optimism over the EPO Enlarged Board of Appeal’s decision in G2/21, say European patent attorneys
Rory O’Neill, March 30, 2023
Berlin / Germany - September 22, 2019: Sanofi Germany - Berlin b
Counsel predict Sanofi victory in SCOTUS enablement case
Significant changes to the standard of law are unlikely, say sources, who note that some justices seemed sceptical that the parties disagreed on the legal standard
Rani Mehta, March 29, 2023
Australian HC.jpeg
Counsel: Australian TM edict could weaken big brands’ power
Sources say the High Court of Australia’s ruling that reputation is immaterial in trademark infringement cases could stop famous brands from muscling out smaller players
Sukanya Sarkar, March 29, 2023
retro banner with red vintage typewriter with a blank sheet of p
US lawmakers blast patent thickets in letter to USPTO director
Three Republican and two Democratic Congress members have claimed that patent thickets hinder access to affordable medicine
Rani Mehta, March 29, 2023
Charles Hoskin, Head of Brand Protection, Shopee.jpg
Good faith goes a long way, says Shopee brand protection head
Charles Hoskin of Singaporean e-commerce platform Shopee, who made the jump from a luxury brand, says honest conversations and collaborations are key to combatting counterfeiting
Sukanya Sarkar, March 29, 2023
Adam Williams.jpg
IP will benefit from government reshuffle: UKIPO CEO
Adam Williams speaks to Managing IP about the legacy of Brexit and why IP has sometimes got ‘lost in the noise’ at Westminster
Rory O’Neill, March 29, 2023